Nandita Sarkar, PhD

Amgen
South San Francisco, CA, United States

Senior Scientist

Disclosure information not submitted.

Presentation(s):

• 0989: Regulatory T Cell Defects in SLE and Therapy with a Novel IL-2 Mutein: Phase 1 Clinical Results with Efavaleukin Alfa

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 0989: Regulatory T Cell Defects in SLE and Therapy with a Novel IL-2 Mutein: Phase 1 Clinical Results with Efavaleukin Alfa

  Monday, November 14, 2022
  1:35 PM – 1:40 PM Eastern Time